Skip to main content
NCBI home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 2001 Oct;38(10):649–657. doi: 10.1136/jmg.38.10.649

The expanding phenotype of laminin α2 chain (merosin) abnormalities: case series and review

K Jones 1, G Morgan 1, H Johnston 1, V Tobias 1, R Ouvrier 1, I Wilkinson 1, K North 1
PMCID: PMC1734735  PMID: 11584042

Abstract

Initial reports of patients with laminin α2 chain (merosin) deficiency had a relatively homogeneous phenotype, with classical congenital muscular dystrophy (CMD) characterised by severe muscle weakness, inability to achieve independent ambulation, markedly raised creatine kinase, and characteristic white matter hypodensity on cerebral magnetic resonance imaging. We report a series of five patients with laminin α2 deficiency, only one of whom has this severe classical CMD phenotype, and review published reports to characterise the expanded phenotype of laminin α2 deficiency, as illustrated by this case series. While classical congenital muscular dystrophy with white matter abnormality is the commonest phenotype associated with laminin α2 deficiency, 12% of reported cases have later onset, slowly progressive weakness more accurately designated limb-girdle muscular dystrophy. In addition, the following clinical features are reported with increased frequency: mental retardation (~6%), seizures (~8%), subclinical cardiac involvement (3-35%), and neuronal migration defects (4%). At least 25% of patients achieve independent ambulation. Notably, three patients with laminin α2 deficiency were asymptomatic, 10 patients had normal MRI (four with LAMA2 mutations reported), and between 10-20% of cases had maximum recorded creatine kinase of less than 1000 U/l. LAMA2 mutations have been identified in 25% of cases. Sixty eight percent of these have the classical congenital muscular dystrophy, but this figure is likely to be affected by ascertainment bias. We conclude that all dystrophic muscle biopsies, regardless of clinical phenotype, should be studied with antibodies to laminin α2. In addition, the use of multiple antibodies to different regions of laminin α2 may increase the diagnostic yield and provide some correlation with severity of clinical phenotype.


Keywords: congenital muscular dystrophy; laminin α2 chain; merosin; skeletal muscle

Full Text

The Full Text of this article is available as a PDF (213.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allamand V., Sunada Y., Salih M. A., Straub V., Ozo C. O., Al-Turaiki M. H., Akbar M., Kolo T., Colognato H., Zhang X. Mild congenital muscular dystrophy in two patients with an internally deleted laminin alpha2-chain. Hum Mol Genet. 1997 May;6(5):747–752. doi: 10.1093/hmg/6.5.747. [DOI] [PubMed] [Google Scholar]
  2. Brett F. M., Loring P., Caesar A., Burke M., Brennan R. P., King M., Farrell M. A. Immunohistochemical evaluation of merosin deficiency in congenital muscular dystrophies. Arch Pathol Lab Med. 1998 Jan;122(1):69–71. [PubMed] [Google Scholar]
  3. Bushby K., Anderson L. V., Pollitt C., Naom I., Muntoni F., Bindoff L. Abnormal merosin in adults. A new form of late onset muscular dystrophy not linked to chromosome 6q2. Brain. 1998 Apr;121(Pt 4):581–588. doi: 10.1093/brain/121.4.581. [DOI] [PubMed] [Google Scholar]
  4. Castro-Gago M. Occidental-type cerebromuscular dystrophy versus congenital muscular dystrophy with merosin deficiency. Childs Nerv Syst. 1998 Oct;14(10):531–531. doi: 10.1007/s003810050267. [DOI] [PubMed] [Google Scholar]
  5. Cil E., Topaloğlu H., Cağlar M., Ozme S. Left ventricular structure and function by echocardiography in congenital muscular dystrophy. Brain Dev. 1994 Jul-Aug;16(4):301–303. doi: 10.1016/0387-7604(94)90027-2. [DOI] [PubMed] [Google Scholar]
  6. Cohn R. D., Herrmann R., Sorokin L., Wewer U. M., Voit T. Laminin alpha2 chain-deficient congenital muscular dystrophy: variable epitope expression in severe and mild cases. Neurology. 1998 Jul;51(1):94–100. doi: 10.1212/wnl.51.1.94. [DOI] [PubMed] [Google Scholar]
  7. Di Blasi C., Mora M., Pareyson D., Farina L., Sghirlanzoni A., Vignier N., Blasevich F., Cornelio F., Guicheney P., Morandi L. Partial laminin alpha2 chain deficiency in a patient with myopathy resembling inclusion body myositis. Ann Neurol. 2000 Jun;47(6):811–816. [PubMed] [Google Scholar]
  8. Dubowitz V. 41st ENMC International Workshop on Congenital Muscular Dystrophy 8-10 March 1996, Naarden, The Netherlands. Neuromuscul Disord. 1996 Aug;6(4):295–306. doi: 10.1016/0960-8966(96)00358-6. [DOI] [PubMed] [Google Scholar]
  9. Dubowitz V. 50th ENMC International Workshop: congenital muscular dystrophy. 28 February 1997 to 2 March 1997, Naarden, The Netherlands. Neuromuscul Disord. 1997 Dec;7(8):539–547. [PubMed] [Google Scholar]
  10. Dubowitz V. 68th ENMC international workshop (5th international workshop): On congenital muscular dystrophy, 9-11 April 1999, Naarden, The Netherlands. Neuromuscul Disord. 1999 Oct;9(6-7):446–454. doi: 10.1016/s0960-8966(99)00074-7. [DOI] [PubMed] [Google Scholar]
  11. Dubowitz V., Fardeau M. Proceedings of the 27th ENMC sponsored workshop on congenital muscular dystrophy. 22-24 April 1994, The Netherlands. Neuromuscul Disord. 1995 May;5(3):253–258. doi: 10.1016/0960-8966(95)90011-x. [DOI] [PubMed] [Google Scholar]
  12. Fardeau M., Tomé F. M., Helbling-Leclerc A., Evangelista T., Ottolini A., Chevallay M., Barois A., Estournet B., Harpey J. P., Fauré S. Dystrophie musculaire congénitale avec déficience en mérosine: analyse clinique, histopathologique, immunocytochimique et génétique. Rev Neurol (Paris) 1996 Jan;152(1):11–19. [PubMed] [Google Scholar]
  13. Farina L., Morandi L., Milanesi I., Ciceri E., Mora M., Moroni I., Pantaleoni C., Savoiardo M. Congenital muscular dystrophy with merosin deficiency: MRI findings in five patients. Neuroradiology. 1998 Dec;40(12):807–811. doi: 10.1007/s002340050689. [DOI] [PubMed] [Google Scholar]
  14. Guicheney P., Vignier N., Zhang X., He Y., Cruaud C., Frey V., Helbling-Leclerc A., Richard P., Estournet B., Merlini L. PCR based mutation screening of the laminin alpha2 chain gene (LAMA2): application to prenatal diagnosis and search for founder effects in congenital muscular dystrophy. J Med Genet. 1998 Mar;35(3):211–217. doi: 10.1136/jmg.35.3.211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Haltia M., Leivo I., Somer H., Pihko H., Paetau A., Kivelä T., Tarkkanen A., Tomé F., Engvall E., Santavuori P. Muscle-eye-brain disease: a neuropathological study. Ann Neurol. 1997 Feb;41(2):173–180. doi: 10.1002/ana.410410208. [DOI] [PubMed] [Google Scholar]
  16. Hayashi Y. K., Engvall E., Arikawa-Hirasawa E., Goto K., Koga R., Nonaka I., Sugita H., Arahata K. Abnormal localization of laminin subunits in muscular dystrophies. J Neurol Sci. 1993 Oct;119(1):53–64. doi: 10.1016/0022-510x(93)90191-z. [DOI] [PubMed] [Google Scholar]
  17. Hayashi Y. K., Ishihara T., Domen K., Hori H., Arahata K. A benign allelic form of laminin alpha 2 chain deficient muscular dystrophy. Lancet. 1997 Apr 19;349(9059):1147–1147. doi: 10.1016/S0140-6736(05)63023-1. [DOI] [PubMed] [Google Scholar]
  18. Hayashi Y. K., Koga R., Tsukahara T., Ishii H., Matsuishi T., Yamashita Y., Nonaka I., Arahata K. Deficiency of laminin alpha 2-chain mRNA in muscle in a patient with merosin-negative congenital muscular dystrophy. Muscle Nerve. 1995 Sep;18(9):1027–1030. doi: 10.1002/mus.880180918. [DOI] [PubMed] [Google Scholar]
  19. Helbling-Leclerc A., Zhang X., Topaloglu H., Cruaud C., Tesson F., Weissenbach J., Tomé F. M., Schwartz K., Fardeau M., Tryggvason K. Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat Genet. 1995 Oct;11(2):216–218. doi: 10.1038/ng1095-216. [DOI] [PubMed] [Google Scholar]
  20. Herrmann R., Straub V., Meyer K., Kahn T., Wagner M., Voit T. Congenital muscular dystrophy with laminin alpha 2 chain deficiency: identification of a new intermediate phenotype and correlation of clinical findings to muscle immunohistochemistry. Eur J Pediatr. 1996 Nov;155(11):968–976. doi: 10.1007/BF02282889. [DOI] [PubMed] [Google Scholar]
  21. Hillaire D., Leclerc A., Fauré S., Topaloglu H., Chiannilkulchaï N., Guicheney P., Grinas L., Legos P., Philpot J., Evangelista T. Localization of merosin-negative congenital muscular dystrophy to chromosome 6q2 by homozygosity mapping. Hum Mol Genet. 1994 Sep;3(9):1657–1661. doi: 10.1093/hmg/3.9.1657. [DOI] [PubMed] [Google Scholar]
  22. Jones K. J., Kim S. S., North K. N. Abnormalities of dystrophin, the sarcoglycans, and laminin alpha2 in the muscular dystrophies. J Med Genet. 1998 May;35(5):379–386. doi: 10.1136/jmg.35.5.379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Mackay M. T., Kornberg A. J., Shield L., Phelan E., Kean M. J., Coleman L. T., Dennett X. Congenital muscular dystrophy, white-matter abnormalities, and neuronal migration disorders: the expanding concept. J Child Neurol. 1998 Oct;13(10):481–487. doi: 10.1177/088307389801301003. [DOI] [PubMed] [Google Scholar]
  24. Martinello F., Angelini C., Trevisan C. P. Congenital muscular dystrophy with partial merosin deficiency and late onset epilepsy. Eur Neurol. 1998 Jul;40(1):37–45. doi: 10.1159/000007954. [DOI] [PubMed] [Google Scholar]
  25. Mercuri E., Dubowitz L., Berardinelli A., Pennock J., Jongmans M., Henderson S., Muntoni F., Sewry C., Philpot J., Dubowitz V. Minor neurological and perceptuo-motor deficits in children with congenital muscular dystrophy: correlation with brain MRI changes. Neuropediatrics. 1995 Jun;26(3):156–162. doi: 10.1055/s-2007-979746. [DOI] [PubMed] [Google Scholar]
  26. Mercuri E., Gruter-Andrew J., Philpot J., Sewry C., Counsell S., Henderson S., Jensen A., Naom I., Bydder G., Dubowitz V. Cognitive abilities in children with congenital muscular dystrophy: correlation with brain MRI and merosin status. Neuromuscul Disord. 1999 Oct;9(6-7):383–387. doi: 10.1016/s0960-8966(99)00034-6. [DOI] [PubMed] [Google Scholar]
  27. Mercuri E., Muntoni F., Berardinelli A., Pennock J., Sewry C., Philpot J., Dubowitz V. Somatosensory and visual evoked potentials in congenital muscular dystrophy: correlation with MRI changes and muscle merosin status. Neuropediatrics. 1995 Feb;26(1):3–7. doi: 10.1055/s-2007-979711. [DOI] [PubMed] [Google Scholar]
  28. Mercuri E., Pennock J., Goodwin F., Sewry C., Cowan F., Dubowitz L., Dubowitz V., Muntoni F. Sequential study of central and peripheral nervous system involvement in an infant with merosin-deficient congenital muscular dystrophy. Neuromuscul Disord. 1996 Dec;6(6):425–429. doi: 10.1016/s0960-8966(96)00383-5. [DOI] [PubMed] [Google Scholar]
  29. Mora M., Moroni I., Uziel G., di Blasi C., Barresi R., Farina L., Morandi L. Mild clinical phenotype in a 12-year-old boy with partial merosin deficiency and central and peripheral nervous system abnormalities. Neuromuscul Disord. 1996 Oct;6(5):377–381. doi: 10.1016/0960-8966(96)00359-8. [DOI] [PubMed] [Google Scholar]
  30. Morandi L., Di Blasi C., Farina L., Sorokin L., Uziel G., Azan G., Pini A., Toscano A., Lanfossi M., Galbiati S. Clinical correlations in 16 patients with total or partial laminin alpha2 deficiency characterized using antibodies against 2 fragments of the protein. Arch Neurol. 1999 Feb;56(2):209–215. doi: 10.1001/archneur.56.2.209. [DOI] [PubMed] [Google Scholar]
  31. Muntoni F., Taylor J., Sewry C. A., Naom I., Dubowitz V. An early onset muscular dystrophy with diaphragmatic involvement, early respiratory failure and secondary alpha2 laminin deficiency unlinked to the LAMA2 locus on 6q22. Eur J Paediatr Neurol. 1998;2(1):19–26. doi: 10.1016/1090-3798(98)01001-9. [DOI] [PubMed] [Google Scholar]
  32. Naom I. S., D'Alessandro M., Topaloglu H., Sewry C., Ferlini A., Helbling-Leclerc A., Guicheney P., Weissenbach J., Schwartz K., Bushby K. Refinement of the laminin alpha2 chain locus to human chromosome 6q2 in severe and mild merosin deficient congenital muscular dystrophy. J Med Genet. 1997 Feb;34(2):99–104. doi: 10.1136/jmg.34.2.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Naom I., D'Alessandro M., Sewry C. A., Philpot J., Manzur A. Y., Dubowitz V., Muntoni F. Laminin alpha 2-chain gene mutations in two siblings presenting with limb-girdle muscular dystrophy. Neuromuscul Disord. 1998 Oct;8(7):495–501. doi: 10.1016/s0960-8966(98)00065-0. [DOI] [PubMed] [Google Scholar]
  34. Nissinen M., Helbling-Leclerc A., Zhang X., Evangelista T., Topaloglu H., Cruaud C., Weissenbach J., Fardeau M., Tomé F. M., Schwartz K. Substitution of a conserved cysteine-996 in a cysteine-rich motif of the laminin alpha2-chain in congenital muscular dystrophy with partial deficiency of the protein. Am J Hum Genet. 1996 Jun;58(6):1177–1184. [PMC free article] [PubMed] [Google Scholar]
  35. North K. N., Specht L. A., Sethi R. K., Shapiro F., Beggs A. H. Congenital muscular dystrophy associated with merosin deficiency. J Child Neurol. 1996 Jul;11(4):291–295. doi: 10.1177/088307389601100406. [DOI] [PubMed] [Google Scholar]
  36. Pegoraro E., Mancias P., Swerdlow S. H., Raikow R. B., Garcia C., Marks H., Crawford T., Carver V., Di Cianno B., Hoffman E. P. Congenital muscular dystrophy with primary laminin alpha2 (merosin) deficiency presenting as inflammatory myopathy. Ann Neurol. 1996 Nov;40(5):782–791. doi: 10.1002/ana.410400515. [DOI] [PubMed] [Google Scholar]
  37. Pegoraro E., Marks H., Garcia C. A., Crawford T., Mancias P., Connolly A. M., Fanin M., Martinello F., Trevisan C. P., Angelini C. Laminin alpha2 muscular dystrophy: genotype/phenotype studies of 22 patients. Neurology. 1998 Jul;51(1):101–110. doi: 10.1212/wnl.51.1.101. [DOI] [PubMed] [Google Scholar]
  38. Philpot J., Cowan F., Pennock J., Sewry C., Dubowitz V., Bydder G., Muntoni F. Merosin-deficient congenital muscular dystrophy: the spectrum of brain involvement on magnetic resonance imaging. Neuromuscul Disord. 1999 Mar;9(2):81–85. doi: 10.1016/s0960-8966(98)00110-2. [DOI] [PubMed] [Google Scholar]
  39. Philpot J., Sewry C., Pennock J., Dubowitz V. Clinical phenotype in congenital muscular dystrophy: correlation with expression of merosin in skeletal muscle. Neuromuscul Disord. 1995 Jul;5(4):301–305. doi: 10.1016/0960-8966(94)00069-l. [DOI] [PubMed] [Google Scholar]
  40. Philpot J., Topaloglu H., Pennock J., Dubowitz V. Familial concordance of brain magnetic resonance imaging changes in congenital muscular dystrophy. Neuromuscul Disord. 1995 May;5(3):227–231. doi: 10.1016/0960-8966(94)00047-d. [DOI] [PubMed] [Google Scholar]
  41. Pini A., Merlini L., Tomé F. M., Chevallay M., Gobbi G. Merosin-negative congenital muscular dystrophy, occipital epilepsy with periodic spasms and focal cortical dysplasia. Report of three Italian cases in two families. Brain Dev. 1996 Jul-Aug;18(4):316–322. doi: 10.1016/0387-7604(96)00028-9. [DOI] [PubMed] [Google Scholar]
  42. Prelle A., Comi G. P., Rigoletto C., Turconi A., Felisari G., Ciscato P., Fortunato F., Messina S., Bresolin N., Mora M. An atypical case of partial merosin deficiency congenital muscular dystrophy. J Neurol. 1997 Jun;244(6):391–395. doi: 10.1007/s004150050110. [DOI] [PubMed] [Google Scholar]
  43. Reed U. C., Marie S. K., Vainzof M., Salum P. B., Levy J. A., Zatz M., Diament A. Congenital muscular dystrophy with cerebral white matter hypodensity. Correlation of clinical features and merosin deficiency. Brain Dev. 1996 Jan-Feb;18(1):53–58. doi: 10.1016/0387-7604(95)00095-x. [DOI] [PubMed] [Google Scholar]
  44. Schuler F., Sorokin L. M. Expression of laminin isoforms in mouse myogenic cells in vitro and in vivo. J Cell Sci. 1995 Dec;108(Pt 12):3795–3805. doi: 10.1242/jcs.108.12.3795. [DOI] [PubMed] [Google Scholar]
  45. Sewry C. A., Naom I., D'Alessandro M., Ferlini A., Philpot J., Mercuri E., Dubowitz V., Muntoni F. The protein defect in congenital muscular dystrophy. Biochem Soc Trans. 1996 May;24(2):281S–281S. doi: 10.1042/bst024281s. [DOI] [PubMed] [Google Scholar]
  46. Sewry C. A., Naom I., D'Alessandro M., Sorokin L., Bruno S., Wilson L. A., Dubowitz V., Muntoni F. Variable clinical phenotype in merosin-deficient congenital muscular dystrophy associated with differential immunolabelling of two fragments of the laminin alpha 2 chain. Neuromuscul Disord. 1997 May;7(3):169–175. doi: 10.1016/s0960-8966(97)00425-2. [DOI] [PubMed] [Google Scholar]
  47. Shorer Z., Philpot J., Muntoni F., Sewry C., Dubowitz V. Demyelinating peripheral neuropathy in merosin-deficient congenital muscular dystrophy. J Child Neurol. 1995 Nov;10(6):472–475. doi: 10.1177/088307389501000610. [DOI] [PubMed] [Google Scholar]
  48. Spyrou N., Philpot J., Foale R., Camici P. G., Muntoni F. Evidence of left ventricular dysfunction in children with merosin-deficient congenital muscular dystrophy. Am Heart J. 1998 Sep;136(3):474–476. doi: 10.1016/s0002-8703(98)70222-4. [DOI] [PubMed] [Google Scholar]
  49. Sunada Y., Edgar T. S., Lotz B. P., Rust R. S., Campbell K. P. Merosin-negative congenital muscular dystrophy associated with extensive brain abnormalities. Neurology. 1995 Nov;45(11):2084–2089. doi: 10.1212/wnl.45.11.2084. [DOI] [PubMed] [Google Scholar]
  50. Tachi N., Kamimura S., Ohya K., Chiba S., Sasaki K. Congenital muscular dystrophy with partial deficiency of merosin. J Neurol Sci. 1997 Oct 3;151(1):25–27. doi: 10.1016/s0022-510x(97)00081-6. [DOI] [PubMed] [Google Scholar]
  51. Tachi N., Ohya K., Chiba S., Matsuo M., Patria S. Y., Matsumura K. Deficiency of syntrophin, dystroglycan, and merosin in a female infant with a congenital muscular dystrophy phenotype lacking cysteine-rich and C-terminal domains of dystrophin. Neurology. 1997 Aug;49(2):579–583. doi: 10.1212/wnl.49.2.579. [DOI] [PubMed] [Google Scholar]
  52. Talim B., Kale G., Topaloglu H., Akçren Z., Caglar M., Gögü S., Elkay M. Clinical and histopathological study of merosin-deficient and merosin-positive congenital muscular dystrophy. Pediatr Dev Pathol. 2000 Mar-Apr;3(2):168–176. doi: 10.1007/s100240050021. [DOI] [PubMed] [Google Scholar]
  53. Tan E., Topaloglu H., Sewry C., Zorlu Y., Naom I., Erdem S., D'Alessandro M., Muntoni F., Dubowitz V. Late onset muscular dystrophy with cerebral white matter changes due to partial merosin deficiency. Neuromuscul Disord. 1997 Mar;7(2):85–89. doi: 10.1016/s0960-8966(96)00421-x. [DOI] [PubMed] [Google Scholar]
  54. Taratuto A. L., Lubieniecki F., Díaz D., Schultz M., Ruggieri V., Saccoliti M., Dubrovsky A. Merosin-deficient congenital muscular dystrophy associated with abnormal cerebral cortical gyration: an autopsy study. Neuromuscul Disord. 1999 Mar;9(2):86–94. doi: 10.1016/s0960-8966(98)00112-6. [DOI] [PubMed] [Google Scholar]
  55. Tomé F. M., Evangelista T., Leclerc A., Sunada Y., Manole E., Estournet B., Barois A., Campbell K. P., Fardeau M. Congenital muscular dystrophy with merosin deficiency. C R Acad Sci III. 1994 Apr;317(4):351–357. [PubMed] [Google Scholar]
  56. Topaloğlu H., Talim B., Vignier N., Helbling-Leclerc A. H., Yetük M., Afşin I. E., Cağlar M., Kale G., Guicheney P. Merosin-deficient congenital muscular dystrophy with severe mental retardation and normal cranial MRI: a report of two siblings. Neuromuscul Disord. 1998 May;8(3-4):169–174. doi: 10.1016/s0960-8966(98)00013-3. [DOI] [PubMed] [Google Scholar]
  57. Trevisan C. P., Martinello F., Ferruzza E., Fanin M., Chevallay M., Tomé F. M. Brain alterations in the classical form of congenital muscular dystrophy. Clinical and neuroimaging follow-up of 12 cases and correlation with the expression of merosin in muscle. Childs Nerv Syst. 1996 Oct;12(10):604–610. doi: 10.1007/BF00261655. [DOI] [PubMed] [Google Scholar]
  58. Tsao C. Y., Mendell J. R., Rusin J., Luquette M. Congenital muscular dystrophy with complete laminin-alpha2-deficiency, cortical dysplasia, and cerebral white-matter changes in children. J Child Neurol. 1998 Jun;13(6):253–256. doi: 10.1177/088307389801300602. [DOI] [PubMed] [Google Scholar]
  59. Vainzof M., Marie S. K., Reed U. C., Schwartzman J. S., Pavanello R. C., Passos-Bueno M. R., Zatz M. Deficiency of merosin (laminin M or alpha 2) in congenital muscular dystrophy associated with cerebral white matter alterations. Neuropediatrics. 1995 Dec;26(6):293–297. doi: 10.1055/s-2007-979777. [DOI] [PubMed] [Google Scholar]
  60. Vajsar J., Chitayat D., Becker L. E., Ho M., Ben-Zeev B., Jay V. Severe classical congenital muscular dystrophy and merosin expression. Clin Genet. 1998 Sep;54(3):193–198. doi: 10.1111/j.1399-0004.1998.tb04283.x. [DOI] [PubMed] [Google Scholar]
  61. Yamashita Y., Ohtaka E., Matsuishi T., Osari S., Kobayashi O., Nonaka I. Merosin-negative non-Fukuyama-type congenital muscular dystrophy: a case report. Brain Dev. 1996 Mar-Apr;18(2):131–134. doi: 10.1016/0387-7604(95)00140-9. [DOI] [PubMed] [Google Scholar]
  62. ter Laak H. J., Leyten Q. H., Gabreëls F. J., Kuppen H., Renier W. O., Sengers R. C. Laminin-alpha2 (merosin), beta-dystroglycan, alpha-sarcoglycan (adhalin), and dystrophin expression in congenital muscular dystrophies: an immunohistochemical study. Clin Neurol Neurosurg. 1998 Mar;100(1):5–10. doi: 10.1016/s0303-8467(97)00109-1. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES